These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

243 related items for PubMed ID: 7747690

  • 21. Hemodynamic effects of a continuous infusion of levosimendan in critically ill patients with cardiogenic shock requiring catecholamines.
    Delle Karth G, Buberl A, Geppert A, Neunteufl T, Huelsmann M, Kopp C, Nikfardjam M, Berger R, Heinz G.
    Acta Anaesthesiol Scand; 2003 Nov; 47(10):1251-6. PubMed ID: 14616323
    [Abstract] [Full Text] [Related]

  • 22. Pharmacokinetics and pharmacodynamics of simendan, a novel calcium sensitizer, in healthy volunteers.
    Lilleberg J, Antila S, Karlsson M, Nieminen MS, Pentkäinen PJ.
    Clin Pharmacol Ther; 1994 Nov; 56(5):554-63. PubMed ID: 7955820
    [Abstract] [Full Text] [Related]

  • 23. Effects of levosimendan on glomerular filtration rate, renal blood flow, and renal oxygenation after cardiac surgery with cardiopulmonary bypass: a randomized placebo-controlled study.
    Bragadottir G, Redfors B, Ricksten SE.
    Crit Care Med; 2013 Oct; 41(10):2328-35. PubMed ID: 23921271
    [Abstract] [Full Text] [Related]

  • 24. The contractility enhancing effect of the calcium sensitiser levosimendan is not attenuated by carvedilol in healthy subjects.
    Lehtonen L, Sundberg S.
    Eur J Clin Pharmacol; 2002 Oct; 58(7):449-52. PubMed ID: 12389066
    [Abstract] [Full Text] [Related]

  • 25. Dose-range study of a new calcium sensitizer, levosimendan, in patients with left ventricular dysfunction.
    Lilleberg J, Sundberg S, Nieminen MS.
    J Cardiovasc Pharmacol; 1995 Oct; 26 Suppl 1():S63-9. PubMed ID: 8907133
    [Abstract] [Full Text] [Related]

  • 26. Levosimendan enhances cardiac performance after cardiopulmonary bypass: a prospective, randomized placebo-controlled trial.
    Nijhawan N, Nicolosi AC, Montgomery MW, Aggarwal A, Pagel PS, Warltier DC.
    J Cardiovasc Pharmacol; 1999 Aug; 34(2):219-28. PubMed ID: 10445673
    [Abstract] [Full Text] [Related]

  • 27. A comparison of dobutamine and levosimendan on hepatic blood flow in patients with a low cardiac output state after cardiac surgery: a randomised controlled study.
    Alvarez J, Baluja A, Selas S, Otero P, Rial M, Veiras S, Caruezo V, Taboada M, Rodriguez I, Castroagudin J, Tome S, Rodriguez A, Rodriguez J.
    Anaesth Intensive Care; 2013 Nov; 41(6):719-27. PubMed ID: 24180712
    [Abstract] [Full Text] [Related]

  • 28. Effect of the calcium sensitizer levosimendan on the performance of ischaemic myocardium in anaesthetised pigs.
    Tassani P, Schad H, Heimisch W, Bernhard-Abt A, Ettner U, Mendler N, Lange R.
    Cardiovasc Drugs Ther; 2002 Sep; 16(5):435-41. PubMed ID: 12652113
    [Abstract] [Full Text] [Related]

  • 29. Comparative hemodynamic effects of levosimendan alone and in conjunction with 4-aminopyridine or calcium chloride in a rodent model of severe verapamil poisoning.
    Graudins A, Wong KK.
    J Med Toxicol; 2010 Jun; 6(2):85-93. PubMed ID: 20473651
    [Abstract] [Full Text] [Related]

  • 30. Levosimendan is superior to milrinone and dobutamine in selectively increasing microvascular gastric mucosal oxygenation in dogs.
    Schwarte LA, Picker O, Bornstein SR, Fournell A, Scheeren TW.
    Crit Care Med; 2005 Jan; 33(1):135-42; discussion 246-7. PubMed ID: 15644660
    [Abstract] [Full Text] [Related]

  • 31. Zatebradine, a specific bradycardic agent, alters the hemodynamic and left ventricular mechanical actions of levosimendan, a new myofilament calcium sensitizer, in conscious dogs.
    Pagel PS, Harkin CP, Hettrick DA, Warltier DC.
    J Pharmacol Exp Ther; 1995 Oct; 275(1):127-35. PubMed ID: 7562540
    [Abstract] [Full Text] [Related]

  • 32. Hemodynamic, neurohumoral, and myocardial energetic effects of pimobendan, a novel calcium-sensitizing compound, in patients with mild to moderate heart failure.
    Remme WJ, Kruijssen DA, van Hoogenhuyze DC, Krauss XH, Bartels GL, Storm CJ, de Leeuw PW.
    J Cardiovasc Pharmacol; 1994 Nov; 24(5):730-9. PubMed ID: 7532750
    [Abstract] [Full Text] [Related]

  • 33. Haemodynamic effects of levosimendan for low cardiac output after cardiac surgery: a case series.
    Malliotakis P, Xenikakis T, Linardakis M, Hassoulas J.
    Hellenic J Cardiol; 2007 Nov; 48(2):80-8. PubMed ID: 17489345
    [Abstract] [Full Text] [Related]

  • 34. Levosimendan attenuates hypoxia-induced pulmonary hypertension in a porcine model.
    Wiklund A, Kylhammar D, Rådegran G.
    J Cardiovasc Pharmacol; 2012 May; 59(5):441-9. PubMed ID: 22240915
    [Abstract] [Full Text] [Related]

  • 35. Effects of levosimendan, a novel inotropic calcium-sensitizing drug, in experimental septic shock.
    Oldner A, Konrad D, Weitzberg E, Rudehill A, Rossi P, Wanecek M.
    Crit Care Med; 2001 Nov; 29(11):2185-93. PubMed ID: 11700420
    [Abstract] [Full Text] [Related]

  • 36. Oral levosimendan prevents postinfarct heart failure and cardiac remodeling in diabetic Goto-Kakizaki rats.
    Louhelainen M, Vahtola E, Forsten H, Merasto S, Kytö V, Finckenberg P, Leskinen H, Kaheinen P, Tikkanen I, Levijoki J, Mervaala E.
    J Hypertens; 2009 Oct; 27(10):2094-107. PubMed ID: 19730126
    [Abstract] [Full Text] [Related]

  • 37. Levosimendan improves LV systolic and diastolic performance at rest and during exercise after heart failure.
    Tachibana H, Cheng HJ, Ukai T, Igawa A, Zhang ZS, Little WC, Cheng CP.
    Am J Physiol Heart Circ Physiol; 2005 Feb; 288(2):H914-22. PubMed ID: 15486041
    [Abstract] [Full Text] [Related]

  • 38. A comparison of hemodynamic effects of levosimendan and dobutamine in patients undergoing mitral valve repair / replacement for severe mitral stenosis.
    Gandham R, Syamasundar A, Ravulapalli H, Karthekeyan RB, Vakamudi M, Kodalli R, Nandipati S.
    Ann Card Anaesth; 2013 Feb; 16(1):11-5. PubMed ID: 23287080
    [Abstract] [Full Text] [Related]

  • 39. Levosimendan improves cardiac function and survival in rats with angiotensin II-induced hypertensive heart failure.
    Biala A, Martonen E, Kaheinen P, Levijoki J, Finckenberg P, Merasto S, Louhelainen M, Muller DN, Luft FC, Mervaala E.
    Hypertens Res; 2010 Oct; 33(10):1004-11. PubMed ID: 20811386
    [Abstract] [Full Text] [Related]

  • 40. Hemodynamic and neurohumoral effects of continuous infusion of levosimendan in patients with congestive heart failure.
    Nieminen MS, Akkila J, Hasenfuss G, Kleber FX, Lehtonen LA, Mitrovic V, Nyquist O, Remme WJ.
    J Am Coll Cardiol; 2000 Nov 15; 36(6):1903-12. PubMed ID: 11092663
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 13.